IDO expression, staging, tumour grade 3 were prognostic for poorer overall survival. IDO was a prognostic factor in patients who received adjuvant (radio)chemotherapy, but had no impact in patients without adjuvant therapy. This evidence concerns the gene IDO1 and neoplasm.